TC
BEAT

TradeLink Capital’s BioTelemetry, Inc. BEAT Stock Holding History

TradeLink Capital’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,500
Closed -$15K – 433
2014
Q1 		$15K Buy
+1,500
New +$13.8K 0.02% 215

Other funds holding BEAT

CPIM
Columbia Partners Investment Management Alexandria, Virginia $257M AUM 8.17% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

TradeLink Capital's BEAT Position: Q2 2014 in Review

TradeLink Capital sold out of BioTelemetry, Inc. (BEAT) in Q2 2014, closing a stake of 1,500 shares — an estimated $15K sold.

TradeLink Capital first reported a position in BEAT in Q1 2014 and held it in 1 quarter. The position peaked at $15K in Q1 2014. 93 funds tracked by Wall St. Rank hold BEAT as of Q2 2014.

  • TradeLink Capital reported no remaining BioTelemetry, Inc. position as of Q2 2014 after selling out during the quarter.
  • TradeLink Capital sold 1,500 BioTelemetry, Inc. shares in Q2 2014, an estimated $15K.
  • TradeLink Capital first reported a position in BioTelemetry, Inc. in Q1 2014 and held it in 1 quarter.
  • TradeLink Capital's BioTelemetry, Inc. position peaked at $15K in Q1 2014.
  • 93 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2014.

Based on TradeLink Capital's 13F filing for Q2 2014, filed 31 Jul 2014.